Having trouble accessing articles? Reset your cache.

Somaxon jumps on Silenor deal

Somaxon Pharmaceuticals Inc. (NASDAQ:SOMX) gained $0.97 (29%) to $4.34 on Wednesday after it granted Procter & Gamble Co. (NYSE:PG) rights

Read the full 200 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE